These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 9920256

  • 1. Billion-dollar market blossoms as botanicals take root.
    Glaser V.
    Nat Biotechnol; 1999 Jan; 17(1):17-8. PubMed ID: 9920256
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Market watch: upcoming market catalysts in Q2 2011.
    Jeng R.
    Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455226
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New clinical trials policy at FDA.
    Vastag B.
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA.
    Food Drug Law J; 2003 Sep; 58(1):103-27. PubMed ID: 12739592
    [No Abstract] [Full Text] [Related]

  • 10. The problem of new uses.
    Eisenberg RS.
    Yale J Health Policy Law Ethics; 2005 Sep; 5(2):717-39. PubMed ID: 16052897
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Market exclusivity for biologics.
    Wheadon DE.
    N Engl J Med; 2010 Feb 18; 362(7):661; author reply 661-2. PubMed ID: 20164494
    [No Abstract] [Full Text] [Related]

  • 13. Experimental use and the Orphan Drug Act: a biotechnology conundrum.
    Koivuniemi PJ.
    Nat Biotechnol; 1996 Apr 18; 14(4):511-2. PubMed ID: 9630930
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New guides to herbal remedies.
    Harv Womens Health Watch; 1999 Feb 18; 6(6):2-3. PubMed ID: 9973889
    [No Abstract] [Full Text] [Related]

  • 16. Market watch: upcoming market catalysts in Q1 2013.
    Inui E.
    Nat Rev Drug Discov; 2013 Jan 18; 12(1):12. PubMed ID: 23274459
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A critical tipping point.
    Zuckerman MB.
    US News World Rep; 2002 Apr 22; 132(13):72. PubMed ID: 11993366
    [No Abstract] [Full Text] [Related]

  • 20. Alternative medicine--the risks of untested and unregulated remedies.
    Angell M, Kassirer JP.
    N Engl J Med; 1998 Sep 17; 339(12):839-41. PubMed ID: 9738094
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.